Robert J. Gray - Concepedia

Author

Robert J. Gray

Also Known As

Anne Bezanson, Anthony Fyles, Badve, Sunil S, Gray, R, Gray, Robert, Gray, Robert J, Lively, Tracy, R GRAY, R Gray, R J Gray

352

Publications

26.7K

Citations

H-Index

129

Concepts

All Affiliations

Dana-Farber Cancer Institute National Cancer Institute University of Pennsylvania Massachusetts General Hospital The University of Texas MD Anderson Cancer Center

About

Robert J. Gray is an author at Dana-Farber Cancer Institute specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	49	4.5K
2	Health Sciences	14	16	748
3	Engineering	9	9	728
4	Law	1	1	20
5	Management	1	1	1.3K

Robert J. Gray

135

Publications

25.7K

Citations

H-Index

Page 1

	Year	Citations
Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer Alan Sandler, Robert J. Gray, Michael C. Perry, New England Journal of Medicine	2006	5.8K
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer Joseph A. Sparano, Robert J. Gray, Della Makower, New England Journal of Medicine	2018	2.3K
Prospective Validation of a 21-Gene Expression Assay in Breast Cancer Joseph A. Sparano, Robert J. Gray, Della Makower, New England Journal of Medicine	2015	1.4K
Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199 Sylvia Adams, Robert J. Gray, Sandra Demaria, Journal of Clinical Oncology	2014	1.3K
A Proportional Hazards Model for the Subdistribution of a Competing Risk Jason P. Fine, Robert J. Gray Journal of the American Statistical Association PrognosisRare Event EstimationRisk MetricRisk AnalysisEmerging Risk	1999	1.3K
Proposal for Standardized Definitions for Efficacy End Points in Adjuvant Breast Cancer Trials: The STEEP System Clifford A. Hudis, William E. Barlow, Joseph P. Costantino, Journal of Clinical Oncology	2007	860
Annual hazard rates of recurrence for breast cancer after primary therapy. T Saphner, Douglas C. Tormey, Robert J. Gray Journal of Clinical Oncology	1996	831
Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers Sherene Loi, Damien Drubay, Sylvia Adams, Journal of Clinical Oncology	2019	828
Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer Joseph A. Sparano, Robert J. Gray, Peter M. Ravdin, New England Journal of Medicine	2019	532
Flexible Methods for Analyzing Survival Data Using Splines, with Applications to Breast Cancer Prognosis Robert J. Gray Journal of the American Statistical Association Breast OncologyPrognosisEpidemiology Of CancerCancer RegistrationBreast Cancer Prognosis	1992	484

Page 1